Terms: = Lymphoma AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Prognosis
31 results:
1. Primary central nervous system marginal zone lymphoma.
Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
[TBL] [Abstract] [Full Text] [Related]
2. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
3. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract] [Full Text] [Related]
4. Genetic Profiling of Diffuse Large B-Cell lymphoma: A Comparison Between Double-Expressor lymphoma and Non-Double-Expressor lymphoma.
Chen H; Qin Y; Liu P; Yang J; Gui L; He X; Zhang C; Zhou S; Zhou L; Yang S; Shi Y
Mol Diagn Ther; 2023 Jan; 27(1):75-86. PubMed ID: 36401148
[TBL] [Abstract] [Full Text] [Related]
5. Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and prognosis of Primary Central Nervous System lymphoma.
Jin Q; Jiang H; Han Y; Li C; Zhang L; Zhang Y; Chai Y; Zeng P; Yue L; Wu C
World Neurosurg; 2023 Feb; 170():99-106. PubMed ID: 36396049
[TBL] [Abstract] [Full Text] [Related]
6. tnfaip3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
Chen C; Zhou L; Zhu L; Luo G; Wang L; Zeng C; Zhou H; Li Y
Cancer Med; 2023 Feb; 12(4):3952-3961. PubMed ID: 36056685
[TBL] [Abstract] [Full Text] [Related]
7. Genomic Mutation Landscape of Primary Breast lymphoma: Next-Generation Sequencing Analysis.
Zhang W; Huang C; Liu J; Wu L; Zhang H; Wu X; Wang L; Li W; Liu W; Liu L
Dis Markers; 2022; 2022():6441139. PubMed ID: 35937947
[TBL] [Abstract] [Full Text] [Related]
8. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
[TBL] [Abstract] [Full Text] [Related]
9. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract] [Full Text] [Related]
10. Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping.
Alcoceba M; García-Álvarez M; Chillón MC; Jiménez C; Medina A; Antón A; Blanco O; Díaz LG; Tamayo P; González-Calle V; Vidal MJ; Cuello R; Díaz Gálvez FJ; Queizán JA; Martín A; González M; García-Sanz R; Sarasquete ME
Br J Haematol; 2021 Nov; 195(4):542-551. PubMed ID: 34312841
[TBL] [Abstract] [Full Text] [Related]
11. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
[TBL] [Abstract] [Full Text] [Related]
12. Development of molecular intervention strategies for B-cell lymphoma.
Zhou W; Chen W
Expert Rev Hematol; 2021 Feb; 14(2):241-252. PubMed ID: 33263441
[TBL] [Abstract] [Full Text] [Related]
13. Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer.
Tao H; Shi L; Zhou A; Li H; Gai F; Huang Z; Che N; Liu Z
Lung Cancer; 2020 Nov; 149():154-161. PubMed ID: 33017727
[TBL] [Abstract] [Full Text] [Related]
14. [Low-grade dural extranodal marginal zone lymphoma].
Marguet F; Fontanilles M; Bohers E; Derrey S; Langlois O; Veresezan L; Leprêtre S; Sabourin JC; Jardin F; Laquerrière A
Ann Pathol; 2020 Jun; 40(3):243-247. PubMed ID: 31948699
[TBL] [Abstract] [Full Text] [Related]
15. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
[TBL] [Abstract] [Full Text] [Related]
16. Activation of the NF-κB Pathway and Heterozygous Deletion of tnfaip3 (a20) Confer Superior Survival in Extranodal Natural Killer/T-Cell lymphoma, Nasal Type.
Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
[TBL] [Abstract] [Full Text] [Related]
17. Cyclin D1-positive Mediastinal Large B-Cell lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
Chen BJ; Ruminy P; Roth CG; Bisig B; Mankel B; Steinhilber J; Bohers E; Jardin F; Fend F; Swerdlow SH; Copie-Bergman C; de Leval L; Quintanilla-Martinez L
Am J Surg Pathol; 2019 Jan; 43(1):110-120. PubMed ID: 30211726
[TBL] [Abstract] [Full Text] [Related]
18. Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.
Hiemcke-Jiwa LS; Leguit RJ; Snijders TJ; Jiwa NM; Kuiper JJW; de Weger RA; Minnema MC; Huibers MMH
Crit Rev Oncol Hematol; 2018 Jul; 127():56-65. PubMed ID: 29891112
[TBL] [Abstract] [Full Text] [Related]
19. B-cell Function Gene Mutations in Diffuse Large B-cell lymphoma: A Retrospective Cohort Study.
Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
[TBL] [Abstract] [Full Text] [Related]
20. Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity.
Bhatt S; Parvin S; Zhang Y; Cho HM; Kunkalla K; Vega F; Timmerman JM; Shin SU; Rosenblatt JD; Lossos IS
Blood; 2017 Apr; 129(16):2246-2256. PubMed ID: 28137826
[TBL] [Abstract] [Full Text] [Related]
[Next]
